⌘K
Loading ticker…
As of 2026-08-24, DENTSPLY SIRONA Inc. (XRAY) has a 3-month relative strength percentile of 61 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.8%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
XRAY is in a stage 1 base, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -9.3% / -7.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
XRAY is held by 30 ETFs as of May 2026. Top owner: SCHA at 0.04% weight, $10M notional. Top 3 carry $21M.
Held by 91 ETFs · $420M across latest filings · largest weight 4.61% (PRNT).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $10M | −0.02 pp |
| VHTVanguard Health Care ETF | 0.03% | $6M | −0.01 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.02% | $5M | — |
| AVSC | 0.14% | $4M | −0.06 pp |
| IVOO | 0.06% |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $3M |
| −0.03 pp |
| IVOV | 0.12% | $2M | −0.05 pp |
| RWK | 0.11% | $1M | −0.07 pp |
| VONVVanguard Russell 1000 Value ETF | 0.01% | $1M | — |
| VFVA | 0.15% | $1M | +0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
Showing 10 of 30 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XRAY Jan avg: 6.63% median: 6.60% win: 75% σ: 7.64% n: 4 2022-04-12 → 2026-07-31 | XRAY Feb avg: -0.28% median: -1.29% win: 50% σ: 14.43% n: 4 2022-04-12 → 2026-07-31 | XRAY Mar avg: -6.49% median: -4.08% win: 50% σ: 11.24% n: 4 2022-04-12 → 2026-07-31 | XRAY Apr avg: -5.20% median: -6.96% win: 40% σ: 9.47% n: 5 2022-04-12 → 2026-07-31 | XRAY May avg: -3.50% median: -6.66% win: 20% σ: 11.39% n: 5 2022-04-12 → 2026-07-31 | XRAY Jun avg: -1.85% median: -0.63% win: 40% σ: 8.91% n: 5 2022-04-12 → 2026-07-31 | XRAY Jul avg: 6.01% median: 3.75% win: 80% σ: 13.13% n: 5 2022-04-12 → 2026-07-31 | XRAY Aug avg: -6.73% median: -8.10% win: 0% σ: 4.72% n: 4 2022-04-12 → 2026-07-31 (current) | XRAY Sep avg: -6.41% median: -9.58% win: 25% σ: 9.23% n: 4 2022-04-12 → 2026-07-31 | XRAY Oct avg: -4.32% median: -5.80% win: 25% σ: 10.47% n: 4 2022-04-12 → 2026-07-31 | XRAY Nov avg: -5.67% median: -5.94% win: 25% σ: 8.69% n: 4 2022-04-12 → 2026-07-31 | XRAY Dec avg: 3.67% median: 3.01% win: 75% σ: 6.63% n: 4 2022-04-12 → 2026-07-31 |